Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes
Julie A. Lovshin(Sunnybrook Health Science Centre), David Z.I. Cherney(University Health Network), Michael H. Brent(University of Toronto), Sam Santiago(University Health Network), Hillary A. Keenan(Joslin Diabetes Center), Leif E. Lovblom(University of Toronto), Petter Bjornstad(University of Colorado Denver), Johnny-Wei Bai(Mount Sinai Hospital), Alanna Weisman(Mount Sinai Hospital), Narinder Paul(University Health Network), Yuliya Lytvyn(University Health Network), Andrej Orszag(University of Toronto), Vera Bril(University Health Network), Geneviève Boulet(University of Toronto), Bruce A. Perkins(Sinai Health System), Mohammed A. Farooqi(Mount Sinai Hospital), Daniel Scarr(Mount Sinai Hospital)
Cited by 60
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
State of the Art: Iterative CT Reconstruction Techniques
|Radiology|2015|704
Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
|Diabetes|2010|497
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
|Nature Medicine|2017|493
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470